subject:( End stage renal Disease ESRD )

1. Teodorova, Iliana / Теодорова, Илиана. Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии.

Degree: 2017, Medical University of Varna

URL: http://repository.mu-varna.bg/handle/nls/328

► [EN] Proteinuria is an important marker for the diagnosis and monitoring of the activity of chronic glomerulopathies. It is associated with increased cardiovascular risk and… (more)

▼ [EN] Proteinuria is an important marker for the diagnosis and monitoring of the activity of chronic glomerulopathies. It is associated with increased cardiovascular risk and the risk of progressive deterioration of the renal function. Modern science has a number of serum and urinary biomarkers that have not yet been widely used in nephrology. The subject of this thesis is an analysis of one of the leading reasons for chronic kidney disease (CKD) – the chronic glomerulopathy. The significance of the problem is determined by the fact that glomerulonephritis (GN) is the third leading cause for end-stage renal disease (ESRD) in the European population as well. In this study we set the objective to examine the predicting value of Upr/Uosm, Ualb/Uosm ratios for 24h proteinuria in patients with chronic glomerular disorders. We used a correlation analysis. The results are showing significant connections between the examined parameters - Upr/Uosm, Ualb/Uosm ratios in spot urine and 24h proteinuria, and the strongest link is between 24h proteinuria and Upr/Uosm ratio (r=0,517, p <0,001). Through the use of regression analysis we examined which and how precise the Upr/Uosm and Ualb/Uosm ratios could determine the amount of 24h proteinuria. This is the first of its kind clinical study in Bulgaria which uses Uosm as a reachable, trustworthy and valuable laboratory marker for evaluating the activity of the renal disease. For the first time it is established that Upr/Uosm and Ualb/Uosm ratios in spot urine could be an adequate and sufficient laboratory marker for the activity of primary and secondary glomerular disorders. ///////////////// ///////////////// [BG] Протеинурията е основен маркер за диагностика и проследяване активността на хроничните гломерулопатии. Тя се асоциира с повишен сърдечно-съдов риск и риск от прогресивно влошаване на бъбречната функция. Днес науката разполага с редица съвременни серумни и уринни биомаркери, които все още не са намерили широка употреба в нефрологичната практика. Направеният задълбочен анализ на уринните показатели показа, че отношенията Upr/Ucr и Ualb/Ucr в случайна порция урина могат да се използват като скринингови тестове при пациенти с ХГП. Сравнителното проучване на отношенията Upr/Uosm и Ualb/Uosm с утвърдените в практиката отношения Upr/Ucr и Ualb/Ucr показаха много добра съпоставимост, което предлага разширяване на спектъра от неинвазивни методи за проследяване активността и прогресията на ХГП. Резултатите показаха, че отношението Upr/Uosm е достоверен показател за продължително проследяване активността на бъбречното заболяване. Установено беше, че отношението Ualb/Uosm в случайна порция урина може да служи като чувствителен показател за регистриране тенденция към ремисия или настъпила ремисия на заболяването. Възможността отношението Upr/Uosm да бъде надежден предиктор за 24ч протеинурия, позволява да бъде преоценена необходимостта от количествено изследване на 24 часова белтъчна загуба. Използването на случайна порция урина е практически приложима проба с висока достоверност на…

Subjects/Keywords: chronic kidney disease (CKD); end-stage renal disease (ESRD); proteinuria; glomerulonephritis (GN); chronic glomerulopathy; urinary biomarkers; Неврохирургия / Neurosurgery

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Teodorova, Iliana / Теодорова, �. (2017). Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии. (Thesis). Medical University of Varna. Retrieved from http://repository.mu-varna.bg/handle/nls/328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Teodorova, Iliana / Теодорова, Илиана. “Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии.” 2017. Thesis, Medical University of Varna. Accessed March 07, 2021. http://repository.mu-varna.bg/handle/nls/328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Teodorova, Iliana / Теодорова, Илиана. “Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии.” 2017. Web. 07 Mar 2021.

Vancouver:

Teodorova, Iliana / Теодорова �. Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии. [Internet] [Thesis]. Medical University of Varna; 2017. [cited 2021 Mar 07]. Available from: http://repository.mu-varna.bg/handle/nls/328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Teodorova, Iliana / Теодорова �. Markers for Evaluation of the Activity and Progression of the Kidney Disease in Adult Patients with Chronic Glomerular Disorders /// Показатели за оценка на активността и прогресията на бъбречното заболяване при възрастни пациенти с хронични гломерулопатии. [Thesis]. Medical University of Varna; 2017. Available from: http://repository.mu-varna.bg/handle/nls/328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Oarde, Kristian. Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis .

Degree: 2017, University of Arizona

URL: http://hdl.handle.net/10150/626645

► Background: End-stage renal disease (ESRD) is a chronic medical condition where 90% or more of the kidneys are nonfunctional (Doig & Huether, 2014). The current… (more)

▼ Background: End-stage renal disease (ESRD) is a chronic medical condition where 90% or more of the kidneys are nonfunctional (Doig & Huether, 2014). The current treatment for ESRD is Hemodialysis [HD] (National Institute of Diabetes and Digestive and Kidney Disease [NIDDK], 2013). Individuals who have ESRD who undergo HD suffer from tremendous symptom and treatment burden that affects various facets of life (Axelsson, Klang, Hagelin, Jacobson, & Gleissman, 2014; Axelsson et al., 2012; Tamura & Cohen, 2010). Unfortunately, the symptom and treatment burden associated with ESRD are underrecognized and undertreated (Feely et al., 2016; Gelfman & Meyer, 2012; Murtagh, Addington-Hall, & Higginson, 2007; Russon & Mooney, 2010; Tamura & Meier, 2013). Purpose: The purpose of this quality improvement project is to explore if ESRD patients in Davita Desert Dialysis are knowledgeable about palliative care and if providing education might change their behavior. The primary aim is to create awareness in patients about PC services in an effort to improve their quality of care through education. Design: A quantitative pre- and post survey approach using qualtrics software was utilized to assess the baseline and post-education knowledge of patients who met the inclusion criteria. Setting: DaVita Desert Dialysis, Sun City, AZ. Intervention: The educational intervention is the viewing of a three-minute voice over presentation about palliative care. Limitations: The sample size was small and exposes this study to marked bias and non-generalizability due to the limited number of recruited individuals. Results: One hundred percent of the individuals in the posttest had better awareness about and knowledge about PC. Conclusion: PC can improve the quality of life of patients that suffer from the undertreated and underrecognized symptom and treatment burden (Tamura & Meier, 2013). Further data and studies will be needed to establish PC in the field of nephrology as it relates to the ESRD population undergoing HD. However, the quality improvement focus of increasing PC awareness among ESRD patients undergoing HD has shown great promise as all participants had increased awareness, knowledge availability, and readiness for PC services. Advisors/Committee Members: Shea, Kimberly (advisor), Shea, Kimberly (committeemember), Carlisle, Heather (committeemember), Gregg, Renee (committeemember).

Subjects/Keywords: DIALYSIS; EDUCATION; END STAGE RENAL DISEASE; ESRD; HEMODIALYSIS; PALLIATIVE CARE

…39 9 ABSTRACT Background: End-stage renal disease (ESRD) is a chronic medical… …prospective cohort Joshi, V. D. (2014). Quality of life in end stage renal disease… …The prevalence of symptoms in end-stage renal disease: A systematic review. Research… …keywords used for the search included dialysis, end stage renal disease, renal disease, kidney… …availability, and readiness for PC services. 11 INTRODUCTION Background Knowledge End-stage renal…

10 more images…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Oarde, K. (2017). Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/626645

Chicago Manual of Style (16^th Edition):

Oarde, Kristian. “Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis .” 2017. Doctoral Dissertation, University of Arizona. Accessed March 07, 2021. http://hdl.handle.net/10150/626645.

MLA Handbook (7^th Edition):

Oarde, Kristian. “Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis .” 2017. Web. 07 Mar 2021.

Vancouver:

Oarde K. Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis . [Internet] [Doctoral dissertation]. University of Arizona; 2017. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10150/626645.

Council of Science Editors:

Oarde K. Palliative Care Education in End-stage Renal Disease Patients Undergoing Hemodialysis . [Doctoral Dissertation]. University of Arizona; 2017. Available from: http://hdl.handle.net/10150/626645

NSYSU

3. Ho, Ya-wen. Proteomic analysis of hemodialysis tube binding proteins.

Degree: Master, Institute of Biomedical Sciences, 2010, NSYSU

URL: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0120110-150951

► Hemodialysis is widely used for kidney failure patients, it is well known that oxidative stress is induced during hemodialysis process. To figure out what kind… (more)

Subjects/Keywords: 2D; hemodialysis; end stage renal disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Ho, Y. (2010). Proteomic analysis of hemodialysis tube binding proteins. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0120110-150951

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Ho, Ya-wen. “Proteomic analysis of hemodialysis tube binding proteins.” 2010. Thesis, NSYSU. Accessed March 07, 2021. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0120110-150951.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Ho, Ya-wen. “Proteomic analysis of hemodialysis tube binding proteins.” 2010. Web. 07 Mar 2021.

Vancouver:

Ho Y. Proteomic analysis of hemodialysis tube binding proteins. [Internet] [Thesis]. NSYSU; 2010. [cited 2021 Mar 07]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0120110-150951.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ho Y. Proteomic analysis of hemodialysis tube binding proteins. [Thesis]. NSYSU; 2010. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0120110-150951

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Ghana

4. Otabil, M.K. Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease .

Degree: 2019, University of Ghana

URL: http://ugspace.ug.edu.gh/handle/123456789/35527

► Background: ESRD is the irreversible damage of a person’s kidney, affecting it normal physiological functions and rendering it fatal if not managed by dialysis or… (more)

▼ Background: ESRD is the irreversible damage of a person’s kidney, affecting it normal physiological functions and rendering it fatal if not managed by dialysis or transplantation. In Ghana, ESRD is managed primarily by hemodialysis until the patient can afford kidney transplantation. However, transplants are accompanied with an immune response by the host immune system resulting in a high probability of organ rejection. Immunosuppressant dosing in combination with other immune regulatory medications are required to prevent transplant rejection. Tacrolimus is a first-line immunosuppressant; however, it has a narrow therapeutic range. Tacrolimus is a known substrate of CYP3A5, CYP3A4 enzymes and an efflux pump, P-glycoprotein. The differences in expression level of the substrates are a contributory factor to the individual variations of the pharmacokinetics of Tacrolimus. General Aim: To determine the genetic polymorphisms in CYP3A5, CYP3A4 and MDR1 genes in Ghanaian patients with End Stage Renal Disease. Method: This is a cross-sectional study that involved 87 ESRD patients, out of which 5 were transplant recipients and 82 were on dialysis. Clinical and demographic data were recorded and the genomic DNA isolated. Samples were genotyped for specific SNPs in CYP3A5*3 6986 A>G rs776746, CYP3A4*1B -290 A>G rs2740574, MDR1_Ex12 1236 C˃T rs1128503, MDR1_Ex26 3435 C>T rs1045642, MDR1_Ex21 2677 G>A rs2032582 and MDR1_Ex21 2677 G˃T rs2032582 using PCR-RFLP. The genetic frequencies of the transplant recipients were analyzed against the patients’ Tacrolimus dose and trough levels. Outcome: The mean age of study participants was recorded as 46 years ±14.39. The etiologies of ESRD were mostly hypertension and diabetes. The frequency of CYP3A5*3 (6986 A˃G) genes expressed showed that 4.6% were mutant. This mutant gene was expressed only among the dialysis patients. The frequency of CYP3A4*1B (-290 A˃G) genes expressed showed that 79.31% were mutant, out of which 80% were from the transplant recipients. A wild-type genotypic frequency of 100% was recorded in the participants for the MDR1_Ex12 (1236 C˃T) gene. Also, a 100% wild-type genotypic frequency was recorded in the participants for the MDR1_Ex21 (2677 G˃A) genes. No homozygous mutant genotype was expressed for MDR1_Ex21 (2677 G˃T) genes, however, 1.15% expressed the heterozygous genotype. None of the participants expressed the mutant genotype TT which affects the level of expressed P-glycoprotein in the transmembrane region of cells. The frequency of MDR1_Ex26 (3435 C˃T) genes expressed showed that 1.15% were mutant genotype. From the Tacrolimus trough level and genotype analysis, four transplant recipients expressing the homozygous variant CYP3A4*1B/*1B recorded significantly lower Tacrolimus trough level (average of 5.95± 1.8 ng/ml) compared to the fifth recipient (10.3ng/ml). There was no clear correlation between the expressed genes of the MDR1 haplotype genes and Tacrolimus trough level.

Subjects/Keywords: End-Stage Renal Disease; Tacrolimus Dose

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Otabil, M. K. (2019). Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease . (Masters Thesis). University of Ghana. Retrieved from http://ugspace.ug.edu.gh/handle/123456789/35527

Chicago Manual of Style (16^th Edition):

Otabil, M K. “Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease .” 2019. Masters Thesis, University of Ghana. Accessed March 07, 2021. http://ugspace.ug.edu.gh/handle/123456789/35527.

MLA Handbook (7^th Edition):

Otabil, M K. “Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease .” 2019. Web. 07 Mar 2021.

Vancouver:

Otabil MK. Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease . [Internet] [Masters thesis]. University of Ghana; 2019. [cited 2021 Mar 07]. Available from: http://ugspace.ug.edu.gh/handle/123456789/35527.

Council of Science Editors:

Otabil MK. Genetic Polymorphisms Affecting Tacrolimus Dose Requirements in Ghanaian Patients with End-Stage Renal Disease . [Masters Thesis]. University of Ghana; 2019. Available from: http://ugspace.ug.edu.gh/handle/123456789/35527

5. 신, 정숙. Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients.

Degree: 2014, Ajou University

URL: http://repository.ajou.ac.kr/handle/201003/10893 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016578

►

BACKGROUND: Left ventricular hypertrophy (LVH) is an independent risk factor for morbidity and mortality in patients with end stage renal disease (ESRD). This study aimed… (more)

▼

BACKGROUND: Left ventricular hypertrophy (LVH) is an independent risk factor for morbidity and mortality in patients with end stage renal disease (ESRD). This study aimed to evaluate impact of dialysis modality on LV geometry by using echocardiography. METHODS: We retrospectively evaluated change in LV mass index (LVMI), relative wall thickness (RWT) and LV geometry, assessed by 2D transthoracic echocardiography, in patients starting dialysis while hospitalized from 2002 to 2012. Patients were classified into hemodialysis (HD) group and peritoneal dialysis (PD) group. Follow-up duration performing echocardiogram was 15±7months in HD group and 17±8 months in PD group. LV geometry was divided into 4 groups as normal LV geometry, concentric remodeling, concentric LVH and eccentric LVH according to LVMI and RWT using cutoff values of 115 (men) or 95 (women) g/m² for LVMI and 0.42 for RWT, both men and women. Severity of LVH was followed ASE recommendation (for men; mild: 116-131g/m2, moderate: 132-148 g/m², severe: ≥149 g/m², for women; mild: 96-108 g/m², moderate:109-121 g/m², severe: ≥122 g/m²) of LVMI. The multivariate analysis was performed to evaluate the independent predictors 10% reduction of LVMI. RESULTS: 84 patients with HD (age 55±13years, 51% male) and 36 patients with PD (age 50±14years, 61% male) were enrolled. Before initiation of dialysis, there were no significant difference of ejection fraction, LVMI, RWT (56±14% vs. 56±14%, p=0.810;166.7±46.0g/m² vs. 167.8±54.6g/m², p=0.910; 0.46±0.10 vs. 0.46±0.08, p=0.960, respectively). Concentric LVH was most common in both groups before initiating dialysis (58% vs. 64%). In HD group, there was no difference in LVMI (166.7±46.0g/m2 vs. 165.5±47.2g/m2, p=0.799) at follow-up, PD group had significant reduction of LVMI (164.8±54.6g/m2 vs. 145.1±43.1g/m2, p=0.021). Incidence of 10% reduction of LVMI was higher in PD group (33% vs. 56%, p=0.026). Predominance of concentric LVH did not changed in both groups at follow-up (61% vs. 61%). Patients with PD had decrease of severe LVH 67% to 50% and increase of normal LV 6% to 22% but it was no significant difference (p=0.090). By multivariable linear regression for predicting 10% LVMI regression, Independent predictors were presence of PD (odds ratio[OR]:2.119, 95% confidence interval [CI]:1.041-4.736, p=0.048), Diabetes mellitus (OR:0.464, 95%CI:0.203-8.213, p=0.033), coronary artery disease (OR:0.339, 95%CI: 0.339-8.213, p=0.037 ), serum calcium (OR:0.579, 95%CI:0.293-1.134, p=0.011). CONCLUSION: Otherwise there was no difference in prevalence of LV geometry pattern on baseline and follow up echocardiography, PD patients had reduction of LVMI and PD was an independent predictor for LVMI reduction.

배경: 좌심방 비대는 말기 신부전 환자에서 사망률을 증가시키는 독립인자이다. 본 연구는 심장 초음파를 이용하여 투석 방법이 좌심방 형태에 미치는 영향을 밝히고자 한다. Methods: 후향적으로 2002년에서 2012년 사이 투석을 시작한 환자에서 2D-경흉부 초음파를 이용하여 좌심방 질량지수(LVMI), 상태적 벽두께 (RWT), 좌심방 형태의 변화를 조사하였다. 투석 방법에 따라 혈액 투석군과 복막 투석 군으로 나누었다. 추적 심초음파를 시행한 시기는 혈액투석15±7 개월, 복막투석군이 17±8 개월로 양군에서 차이는 없었다. 좌심실 형태는 LVMI 가 남자는 115g/m2,…

Advisors/Committee Members: 대학원 의학과, 201024244, 신, 정숙.

Subjects/Keywords: Hypertrophy; Geometry; End stage renal disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

신, �. (2014). Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/10893 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016578

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

신, 정숙. “Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients.” 2014. Thesis, Ajou University. Accessed March 07, 2021. http://repository.ajou.ac.kr/handle/201003/10893 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016578.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

신, 정숙. “Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients.” 2014. Web. 07 Mar 2021.

Vancouver:

신 �. Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients. [Internet] [Thesis]. Ajou University; 2014. [cited 2021 Mar 07]. Available from: http://repository.ajou.ac.kr/handle/201003/10893 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016578.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

신 �. Impact of Dialysis Modality on Left Ventricular Geometry in End Stage Renal Disease Patients. [Thesis]. Ajou University; 2014. Available from: http://repository.ajou.ac.kr/handle/201003/10893 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016578

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

NSYSU

6. Wu, Chien-hsing. The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients.

Degree: Master, Biological Sciences, 2013, NSYSU

URL: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0218113-063450

► INTRODUCTION AND AIMS: Gout is a popular disease worldwide. Traditionally, patients suffering from gout were thought to be at high risk for renal complications and… (more)

▼ INTRODUCTION AND AIMS: Gout is a popular disease worldwide. Traditionally, patients suffering from gout were thought to be at high risk for renal complications and people who had gout always worry about the potential risks of getting a kidney disease. The link between uromodulin (UMOD) and chronic kidney disease (CKD) has attracted much interests in the medical literature and several investigations showed UMOD had active role in CKD progression. To our knowledge, the association of urinary UMOD excretion on gout and non-gout patients with CKD has not been thoroughly investigated. METHODS: A total of 114 Taiwanese patients with stable disease activity selected from a cohort that attended our renal and rheumatology outpatient department were enrolled (Non-Gout patients: 40 ,Gout patients: 74) between Jun. 1, 2011 and Dec. 13, 2012. Patients were divided into CKD group (N=68) and non-CKD (N=46) group. CKD was defined by MDRD equation estimate glomerular filtration rate (eGFR)ï¼60 ml/min per 1.73m2. Their demographic data, laboratory tests including serum creatinine, serum uric acid eGFR, and urinary creatinine and UMOD level were measured. Urinary UMOD excretion was calculated as UMOD/UCR ratio. RESULTS: Using Pearson correlation analysis, urinary UMOD excretion correlated positively with eGFR in patients with Gout. In non-gout patients, urinary UMOD excretion does not correlate with eGFR. Gender, status of DM, gout and hypertension do not show significant difference between CKD group and non-CKD group. However, age (CKD group: 62.2 Â± 13.8, Non-CKD group: 43.9 Â± 12.8, p < 0.0001) and serum uric acid (CKD group: 8.2 Â± 2.2 mg/dl, Non-CKD group: 7.2 Â± 1.7 mg/dl, p <0.05) are significantly different between CKD group and non-CKD group. Urinary UMOD excretion is also statistical significantly between two groups (CKD group: 3.7Â± 4.8, Non-CKD group: 5.8 Â± 6.1, p <0.05). Using multivariate analysis, patients with CKD and gout were associated with lower urinary UMOD excretion than those who have gout alone [Odds Ratio 0.796, 95% confidence interval: 0.665-0.934, p=0.006). Patients with CKD and gout were also more likely to be older (p < 0.001) and have higher uric acid levels (p < 0.05). In non-gout patient, urinary UMOD excretion was not associated with status of CKD instead. CONCLUSIONS: Our study indicates that UMOD might play a role in the relationship between gout and CKD. Further studies with animal model of gout and CKD are mandatory to establish fundamental pathomechanism and explore the clinical implications. Advisors/Committee Members: Chung-Lung Cho (chair), Hsueh-Wen Chang (committee member), Feng-Rong Chuang (chair), Bin Huang (chair).

Subjects/Keywords: End-stage renal disease; Hyperurecemia; Gout; Uromodulin; Chronic kidney disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Wu, C. (2013). The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients. (Thesis). NSYSU. Retrieved from http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0218113-063450

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Wu, Chien-hsing. “The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients.” 2013. Thesis, NSYSU. Accessed March 07, 2021. http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0218113-063450.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Wu, Chien-hsing. “The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients.” 2013. Web. 07 Mar 2021.

Vancouver:

Wu C. The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients. [Internet] [Thesis]. NSYSU; 2013. [cited 2021 Mar 07]. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0218113-063450.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wu C. The Relationship between Urinary Uromodulin Excretion and Chronic Kidney Disease in Gout and Non-Gout Patients. [Thesis]. NSYSU; 2013. Available from: http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0218113-063450

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Alberta

7. Dhillon, Karen JK. Adjustment demands through diagnosis and treatment of end stage renal disease.

Degree: MS, Faculty of Rehabilitation Medicine, 2011, University of Alberta

URL: https://era.library.ualberta.ca/files/2r36tz10w

► End Stage Renal Disease (ESRD) is a chronic illness that results when the kidneys are no longer able to function to maintain life. Upon cessation… (more)

Subjects/Keywords: adjustment; kidney disease; adjustment demands; occupational therapy; end stage renal disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Dhillon, K. J. (2011). Adjustment demands through diagnosis and treatment of end stage renal disease. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/2r36tz10w

Chicago Manual of Style (16^th Edition):

Dhillon, Karen JK. “Adjustment demands through diagnosis and treatment of end stage renal disease.” 2011. Masters Thesis, University of Alberta. Accessed March 07, 2021. https://era.library.ualberta.ca/files/2r36tz10w.

MLA Handbook (7^th Edition):

Dhillon, Karen JK. “Adjustment demands through diagnosis and treatment of end stage renal disease.” 2011. Web. 07 Mar 2021.

Vancouver:

Dhillon KJ. Adjustment demands through diagnosis and treatment of end stage renal disease. [Internet] [Masters thesis]. University of Alberta; 2011. [cited 2021 Mar 07]. Available from: https://era.library.ualberta.ca/files/2r36tz10w.

Council of Science Editors:

Dhillon KJ. Adjustment demands through diagnosis and treatment of end stage renal disease. [Masters Thesis]. University of Alberta; 2011. Available from: https://era.library.ualberta.ca/files/2r36tz10w

University of Alabama

8. Williams, Jacqueline Trask. Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study.

Degree: 2013, University of Alabama

URL: http://purl.lib.ua.edu/97213

your words (Published By University of Alabama Libraries) Advisors/Committee Members: Csikai, Ellen L., Bolland, Kathleen, Martin, Shadi, Payne-Foster, Pamela, Simon, Cassandra, University of Alabama. School of Social Work.

Subjects/Keywords: Electronic Thesis or Dissertation; – thesis; Social work; END STAGE RENAL DISEASE; ESRD; LONG-TERM DIALYSIS

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Williams, J. T. (2013). Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study. (Thesis). University of Alabama. Retrieved from http://purl.lib.ua.edu/97213

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Williams, Jacqueline Trask. “Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study.” 2013. Thesis, University of Alabama. Accessed March 07, 2021. http://purl.lib.ua.edu/97213.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Williams, Jacqueline Trask. “Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study.” 2013. Web. 07 Mar 2021.

Vancouver:

Williams JT. Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study. [Internet] [Thesis]. University of Alabama; 2013. [cited 2021 Mar 07]. Available from: http://purl.lib.ua.edu/97213.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Williams JT. Long-term survival among individuals diagnosed with end stage renal disease: an exploratory study. [Thesis]. University of Alabama; 2013. Available from: http://purl.lib.ua.edu/97213

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Uniwersytet im. Adama Mickiewicza w Poznaniu

9. Humińska - Lisowska, Kinga. STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu .

Degree: 2018, Uniwersytet im. Adama Mickiewicza w Poznaniu

URL: http://hdl.handle.net/10593/23972

► Mimo znacznego rozwoju transplantologii, patofizjologia chronicznej nefropatii nerek nadal pozostaje słabo zrozumiana i jest najważniejszym czynnikiem limitującym długoterminowe przeżycie allograftu nerki. Wydaje się być spowodowana… (more)

Subjects/Keywords: przeszczep nerki; kidney allograft; transplantacja, schyłkowa; transplantation; niewydolność nerek; end stage renal disease (ESRD); zwłóknienie śródmiąższowe i atrofia kanalików; interstitial fibrosi s and tubular atrophy (IF/TA); szlak sygnalizacyjny JAK/STAT; JAK/STAT signaling pathway

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Humińska - Lisowska, K. (2018). STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu . (Doctoral Dissertation). Uniwersytet im. Adama Mickiewicza w Poznaniu. Retrieved from http://hdl.handle.net/10593/23972

Chicago Manual of Style (16^th Edition):

Humińska - Lisowska, Kinga. “STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu .” 2018. Doctoral Dissertation, Uniwersytet im. Adama Mickiewicza w Poznaniu. Accessed March 07, 2021. http://hdl.handle.net/10593/23972.

MLA Handbook (7^th Edition):

Humińska - Lisowska, Kinga. “STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu .” 2018. Web. 07 Mar 2021.

Vancouver:

Humińska - Lisowska K. STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu . [Internet] [Doctoral dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10593/23972.

Council of Science Editors:

Humińska - Lisowska K. STATs, SOCSs jako markery dysfunkcji allograftu nerki – analiza ekspresji genów i polimorfizmów pojedynczego nukleotydu . [Doctoral Dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2018. Available from: http://hdl.handle.net/10593/23972

10. Qazi, Hammad. Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients.

Degree: 2018, University of Waterloo

URL: http://hdl.handle.net/10012/13571

► Background: Research on the factors associated with dialysis withdrawal in chronic dialysis patients has been limited. Authors and clinicians have used different definitions for dialysis… (more)

▼ Background: Research on the factors associated with dialysis withdrawal in chronic dialysis patients has been limited. Authors and clinicians have used different definitions for dialysis withdrawal, resulting in inconsistent findings. This thesis explored the factors associated with dialysis withdrawal defined as “patient refused further treatment or voluntary withdrawal from the dialysis program” in chronic dialysis patients. Methods: This retrospective study extracted patient information from the electronic renal patient management system Nephrocare™, and ClinicalConnect™ at the Grand River Hospital. A total of (N=723) patients who initiated chronic renal dialysis therapy (>30 days of duration) in renal dialysis program at Grand River Hospital (GRH), Ontario, during the period from 1st January, 2012 to 30th September, 2017 were consecutively included in the study. Patients with acute dialysis or patients receiving dialysis before the start of the study were excluded. Age, sex, modality, comorbidities such as diabetes, cardiac disease, hypertension, vascular disease, lung disease, malignancy, dementia, depression and bipolar disorder and aetiology of kidney disease were selected as hypothesis variables and duration of dialysis was the controlled variable in this study. Results: The mean age of the sample was 64.86 years (±14.89) with 62.8% (n=454) males. The most common cause of renal disease was diabetes (33.6%) and the most common comorbidity was hypertension (94.5%). The mean duration of dialysis was 544.80 days (±486.83) days. The prevalence of dialysis withdrawal was 9.41% (n=68) with psychosocial (n= 16; 23.5%) being the most common reason. The final logistic regression model showed that cardiac disease, [= 0.6530; p=0.016], hypertension [= 1.7421; p=0.019], dementia [=1.1125; p=0.008] and age [=0.0342; p=0.002] were significantly associated with dialysis withdrawal, with significant influence of duration of dialysis [=-0.000841; p=0.0092] as a confounder on the above relationship. Conclusion: The study showed age, cardiac disease, hypertension and dementia are significant predictors related to dialysis withdrawal in chronic dialysis population. The findings may help in identifying patients who are susceptible to dialysis withdrawal at the start of dialysis. Future researchers and nephrologists should design and conduct intervention studies focusing on strategies controlling the severity of comorbidities (cardiac disease and hypertension), regular assessment and monitoring of the progression of dementia, and other dialysis program changes to decrease dialysis withdrawal rates in chronic dialysis patients.

Subjects/Keywords: Chronic dialysis; End-stage renal disease (ESRD); Dialysis withdrawal; Dialysis modality

…x28;1, 2). The End Stage Renal Disease (ESRD) or CKD stage 5 represents the… …3 Chapter 2 Literature Review 2.1 End-Stage Renal Disease (ESRD) and Dialysis… …End Stage Renal Disease (ESRD) is the irreversible deterioration of kidney… …in End-Stage Renal Disease (ESRD) Population Modality Definition Hemodialysis… …List of Tables Table 1 Dialysis Treatment Modalities Available in End-Stage Renal Disease…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Qazi, H. (2018). Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/13571

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Qazi, Hammad. “Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients.” 2018. Thesis, University of Waterloo. Accessed March 07, 2021. http://hdl.handle.net/10012/13571.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Qazi, Hammad. “Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients.” 2018. Web. 07 Mar 2021.

Vancouver:

Qazi H. Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients. [Internet] [Thesis]. University of Waterloo; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10012/13571.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Qazi H. Factors Associated with Dialysis Withdrawal in Chronic Dialysis Patients. [Thesis]. University of Waterloo; 2018. Available from: http://hdl.handle.net/10012/13571

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Vyduna, Jennifer Lynn. THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS.

Degree: MS, Dietetics & Nutrition, 2012, University of Kansas

URL: http://hdl.handle.net/1808/11451

► Metabolic acidosis, indicated by low serum bicarbonate levels (CO2), is common in patients with end stage renal disease (ESRD). The specific aim of this project… (more)

Subjects/Keywords: Nutrition; Albumin; Bicarbonate; End stage renal disease; Hemodialysis; Malnutrition; Nutrition indicators in esrd

…acidosis (2). Metabolic acidosis in End Stage Renal Disease (ESRD) is the… …with biopsies (11). Acid-base balance End stage renal disease can result in low… …1.73 m2 4 Severely decreased GFR with a level of 15-29 mL/min/1.73 m2 5 End stage renal… …LITERATURE REVIEW Chronic kidney disease stages The prevalence of ESRD is rising in the United… …this category, hypertension is the second most common cause of renal disease, and glomerular…

4 more images…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Vyduna, J. L. (2012). THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS. (Masters Thesis). University of Kansas. Retrieved from http://hdl.handle.net/1808/11451

Chicago Manual of Style (16^th Edition):

Vyduna, Jennifer Lynn. “THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS.” 2012. Masters Thesis, University of Kansas. Accessed March 07, 2021. http://hdl.handle.net/1808/11451.

MLA Handbook (7^th Edition):

Vyduna, Jennifer Lynn. “THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS.” 2012. Web. 07 Mar 2021.

Vancouver:

Vyduna JL. THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS. [Internet] [Masters thesis]. University of Kansas; 2012. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1808/11451.

Council of Science Editors:

Vyduna JL. THE CORRELATION OF SERUM BICARBONATE AND METABOLIC ACIDOSIS TO ALBUMIN IN HEMODIALYSIS PATIENTS. [Masters Thesis]. University of Kansas; 2012. Available from: http://hdl.handle.net/1808/11451

12. Matsuo, Hiroshi. Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis.

Degree: 博士(医学), 2018, Mie University / 三重大学

URL: http://hdl.handle.net/10076/00017515

►

Background: The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter… (more)

Subjects/Keywords: Aortic valve sclerosis; Echocardiography; End-stage renal disease; Hemodialysis; Left ventricle

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Matsuo, H. (2018). Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis. (Thesis). Mie University / 三重大学. Retrieved from http://hdl.handle.net/10076/00017515

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Matsuo, Hiroshi. “Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis.” 2018. Thesis, Mie University / 三重大学. Accessed March 07, 2021. http://hdl.handle.net/10076/00017515.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Matsuo, Hiroshi. “Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis.” 2018. Web. 07 Mar 2021.

Vancouver:

Matsuo H. Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis. [Internet] [Thesis]. Mie University / 三重大学; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10076/00017515.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Matsuo H. Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients with End-Stage Renal Disease Receiving Chronic Hemodialysis. [Thesis]. Mie University / 三重大学; 2018. Available from: http://hdl.handle.net/10076/00017515

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

13. 戸井田, 達典. Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study).

Degree: 博士(医学), 2017, University of Miyazaki / 宮崎大学

URL: http://hdl.handle.net/10458/6042

以下に掲載:Kidney and Blood Pressure Research. , Volume 41, Issue 4, pp 471-478, doi: http://dx.doi.org/10.1159/000443448

Subjects/Keywords: End stage renal disease; Hemodialysis; Cerebral infarction; Risk factor

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

戸井田, �. (2017). Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study). (Thesis). University of Miyazaki / 宮崎大学. Retrieved from http://hdl.handle.net/10458/6042

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

戸井田, 達典. “Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study).” 2017. Thesis, University of Miyazaki / 宮崎大学. Accessed March 07, 2021. http://hdl.handle.net/10458/6042.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

戸井田, 達典. “Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study).” 2017. Web. 07 Mar 2021.

Vancouver:

戸井田 �. Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study). [Internet] [Thesis]. University of Miyazaki / 宮崎大学; 2017. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10458/6042.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

戸井田 �. Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study). [Thesis]. University of Miyazaki / 宮崎大学; 2017. Available from: http://hdl.handle.net/10458/6042

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. 戸井田, 達典. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).

Degree: 博士(医学), 2017, University of Miyazaki / 宮崎大学

URL: http://hdl.handle.net/10458/6170

►

以下に掲載:Nephrology .2016 , Volume21 , pp236-240, doi:http://dx.doi.org/10.1111/nep.12587

Aim: Although infection is the second leading cause of death in maintenance haemodialysis patients, the effects of glycaemic… (more)

Subjects/Keywords: End stage renal disease; Hemodialysis; Cerebral infarction; Risk factor

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

戸井田, �. (2017). Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study). (Thesis). University of Miyazaki / 宮崎大学. Retrieved from http://hdl.handle.net/10458/6170

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

戸井田, 達典. “Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).” 2017. Thesis, University of Miyazaki / 宮崎大学. Accessed March 07, 2021. http://hdl.handle.net/10458/6170.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

戸井田, 達典. “Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).” 2017. Web. 07 Mar 2021.

Vancouver:

戸井田 �. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study). [Internet] [Thesis]. University of Miyazaki / 宮崎大学; 2017. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10458/6170.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

戸井田 �. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study). [Thesis]. University of Miyazaki / 宮崎大学; 2017. Available from: http://hdl.handle.net/10458/6170

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

15. 이, 민정. Clinical characteristics of end stage renal disease patients at hemodialysis initiation.

Degree: 2014, Ajou University

URL: http://repository.ajou.ac.kr/handle/201003/10936 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000017447

►

The starting time of renal replacement therapy (RRT) is a complicated issue, which is based on multiple factors including clinical, social and laboratory parameters. To… (more)

▼

The starting time of renal replacement therapy (RRT) is a complicated issue, which is based on multiple factors including clinical, social and laboratory parameters. To help make decision on when to start hemodialysis in impending end stage renal disease (ESRD) patients, we investigated the clinical features of ESRD patients at the start of hemodialysis at a university hospital center in Korea. We retrospectively analyzed 409 ESRD patients who were newly started on hemodialysis treatment between January 2010 and December 2012. The most common cause of ESRD was diabetic nephropathy (48.7%), followed by biopsy-proven glomerulonephritis (11.7%). The mean eGFR at the start of hemodialysis, ranging between 5.59 – 7.82 ml/min/1.73m2 (except Nankivell equation), were significantly different according to different equations. The modified Cockcroft-Gault, the MDRD and the CKD-EPI equations showed significant correlations with all categories of chronic kidney disease complications. The main reasons to start hemodialysis were fluid overload (38.4%) and uremic symptoms (35.0%). DM patents were older and started dialysis at higher eGFR levels than non-DM patients (mean eGFR by the MDRD equation, 6.92 ± 3.63 vs 5.41 ± 2.91, p < 0.001). Hemodialysis was started in 59.2% patents through outpatient clinic or admission after outpatient clinic (OPD group), and in the remaining 40.8% patients via emergency department (ER group). In the ER group, hyperkalemia and metabolic acidosis were significantly more severe than the OPD group. We hope our study will provide valuable information on the clinical and laboratory characteristics of the patients at the time of hemodialysis initiation in our current practices.

신대체요법을 언제 시작해야 하는가?”란 물음에 답하는 것은 어려운 일이다. 신대체요법이 임박한 말기신장질환 환자에서 언제 투석을 시작할지에 대한 결정을 돕기 위하여, 본 연구에서는 한국 3차 의료기관에서 혈액투석 시작 시점에서의 말기신장질환 환자의 임상적 특징을 분석하고자 한다. 2010년 1월부터 2012년 12월까지 처음 혈액투석을 시작한 409명의 환자를 후향적으로 분석하였다. 말기신부전의 가장 흔한 원인은 당뇨병성신증 (48.7%) 였으며, 두 번째로 흔한 원인은 조직검사로 증명된 사구체신염 (11.7%)이었다. 혈액투석 시작 시점에서의 사구체 여과율은 5.59 ~ 7.82 ml/min/1.73m2 였다 (Nankivell equation 으로 계산한 사구체 여과율 제외). 이러한 사구체 여과율은 사구체 여과율 계산 공식을 어떤 것을 사용하는가에 따라 통계학적으로 유의한 차이가 있었다 (p ≤ 0.002). 다섯 가지의 사구체 여과율 공식 중에서, Modified Cockcroft-Gault 식, MDRD 식과 CKD-EPI 식이 만성신부전 합병증과 유의한 상관관계를 보였다. 특히 Modified Cockcroft-Gault 식의 경우 변동 계수 (CV; coefficient of variation)가 가장 작았으며, 이는 이 식이 본 연구의 환자들의 eGFR 값을 가장 재현성 있게 나타낸다는 것을 의미한다. 혈액투석을 시작하게 된 주된 이유는 부종 (38.4%), 요독 증세 (35.0%) 였다. 당뇨 환자는 비당뇨 환자에 비하여 더 나이가 많고, 투석 시작시 높은 사구체 여과율을 보였다. 59.2% 의 환자는 외래를 경유하여 혈액투석을 시작하였고, 40.8% 의 환자는 응급실로 내원하여 혈액투석을 시작하였다. 응급실로 내원하여 투석을 시작한 경우, 고칼륨혈증 및 대사성산증이 외래 내원하여 시작한 환자군에 비하여 더 심한 소견을 보였다. 현재 한국에서 행해지고 있는 혈액 투석 시작 시점에서의 말기신장질환 환자들의 임상적 특징 및 혈액검사 자료 등의 자료가 향후 투석 시작 시점을 결정하는데 유용한 정보가 되길 기대한다.

ABSTRACTS i LIST OF FIGURES iii LIST OF TABLES iv I. INTRODUCTION 1 II. METHODS 2 A. Patient selection 2 B. Laboratory data 2 C. Estimated glomerular filtration rate 2 D. Statistical analysis 3 III. RESULTS 4 IV. DISCUSSION 7 REFERENCES 10 FIGURES 12 TABLES 13 국문요약 19

Master

Advisors/Committee Members: 대학원 의학과, 201224111, 이, 민정.

Subjects/Keywords: End stage renal disease; hemodialysis; estimated glomerular filtration rate

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

이, �. (2014). Clinical characteristics of end stage renal disease patients at hemodialysis initiation. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/10936 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000017447

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

이, 민정. “Clinical characteristics of end stage renal disease patients at hemodialysis initiation.” 2014. Thesis, Ajou University. Accessed March 07, 2021. http://repository.ajou.ac.kr/handle/201003/10936 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000017447.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

이, 민정. “Clinical characteristics of end stage renal disease patients at hemodialysis initiation.” 2014. Web. 07 Mar 2021.

Vancouver:

이 �. Clinical characteristics of end stage renal disease patients at hemodialysis initiation. [Internet] [Thesis]. Ajou University; 2014. [cited 2021 Mar 07]. Available from: http://repository.ajou.ac.kr/handle/201003/10936 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000017447.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

이 �. Clinical characteristics of end stage renal disease patients at hemodialysis initiation. [Thesis]. Ajou University; 2014. Available from: http://repository.ajou.ac.kr/handle/201003/10936 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000017447

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Washington

16. Yu, Margaret Katie. Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort.

Degree: 2013, University of Washington

URL: http://hdl.handle.net/1773/23749

► Context: Though the presence of major depression is associated with adverse health outcomes, little is known regarding its associations with long-term renal outcomes in patients… (more)

Subjects/Keywords: depression; diabetes; end-stage renal disease; Medicine; epidemiology

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Yu, M. K. (2013). Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort. (Thesis). University of Washington. Retrieved from http://hdl.handle.net/1773/23749

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Yu, Margaret Katie. “Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort.” 2013. Thesis, University of Washington. Accessed March 07, 2021. http://hdl.handle.net/1773/23749.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Yu, Margaret Katie. “Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort.” 2013. Web. 07 Mar 2021.

Vancouver:

Yu MK. Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort. [Internet] [Thesis]. University of Washington; 2013. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1773/23749.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yu MK. Associations Between Depressive Symptoms and Incident End-Stage Renal Disease in a Diabetic Cohort. [Thesis]. University of Washington; 2013. Available from: http://hdl.handle.net/1773/23749

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Arizona

17. Mohan, Prashanthinie. Geographic and Racial Disparities in Mortality of Dialysis Patients .

Degree: 2020, University of Arizona

URL: http://hdl.handle.net/10150/636692

► BACKGROUND: The incidence rate and hospitalization rate for patients with End Stage Renal Disease (ESRD) vary across different counties in the U.S. Little information is… (more)

▼ BACKGROUND: The incidence rate and hospitalization rate for patients with End Stage Renal Disease (ESRD) vary across different counties in the U.S. Little information is available on how geography can impact patient mortality through county health status and gaps in supply and demand for hemodialysis services. METHODS: This is a retrospective cohort study where adult patients who initiated in-center hemodialysis between 2007 and 2016 and recorded in the United States Renal Data System (USRDS) were assessed for survival time and mortality rate. The primary exposure variable in Aim 1 was the overall county health status (Most Healthy vs Least Healthy) based on the health factor ranks published by County Health Rankings & Roadmap (CHR&R). The primary exposure variable for Aim 2 was the supply-demand gap for hemodialysis services as measured by the patient-station ratio for each county. The primary exposure variable for Aim 3 was the change in the number of dialysis stations between 2011 and 2016 for each county. Kaplan-Meier estimate used to compute the median survival time and Cox regression analysis was used to compute the hazard rate (HR) for mortality after adjusting for various confounders. RESULTS: Most Healthy counties in the U.S. are likely to be larger urban counties with predominantly white and older patients. On the contrary, Least Healthy counties are comparatively more rural and smaller counties with a higher percentage of African American population, more unemployed and Medicaid patients. Patients residing in Most Healthy counties (HR = 0.899, 95% CI 0.825,0.979) had a lower hazard rate (HR) for mortality compared to patients living in Least Healthy Counties (p value = 0.0143). In Aim 2, counties in Category 1 (counties with no hemodialysis stations), Category 2.1 (underutilized HD stations with population <50,000) and Category 2.2 (underutilized HD stations with population 50,000) had higher HR compared to the reference Category 3. However, when stratified by age and race, the HR was statistically significant for Blacks only for Category 2.2 for all age groups (HR = 1.11, 95% CI 1.06,1.16) and for Whites for Category 1 (aged 40 – 79; HR=1.1) and Category 2.2 (aged 65 – 79; HR=1.11). In Aim 3, counties with No Change had a marginally higher hazard rate (HR=1.04, 95% CI 1.02, 1.07) compared to counties with an increase in dialysis stations. Race was a significant confounder but not an effect modifier to this association (p-value 0.2942). CONCLUSION: County health status and lack of hemodialysis facilities affects survival of ESRD patients. Additionally, patients residing in some suburban counties or smaller metros had a higher hazard rate for mortality despite excess supply of dialysis stations. It is important for care providers and local health officials to understand the health factor profile and spatial distribution of dialysis stations in their county to help ESRD patients navigate barriers to care, reduce rates of dialysis withdrawal, and improve mortality outcomes. Advisors/Committee Members: Calhoun, Elizabeth A (advisor), Roy-Chaudhury, Prabir (committeemember), Barraza, Leila Fs (committeemember), Gilliland, Stephen (committeemember).

Subjects/Keywords: Dialysis; Disparities; End-Stage Renal Disease; Hemodialysis; Mortality; Survival Analysis

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Mohan, P. (2020). Geographic and Racial Disparities in Mortality of Dialysis Patients . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/636692

Chicago Manual of Style (16^th Edition):

Mohan, Prashanthinie. “Geographic and Racial Disparities in Mortality of Dialysis Patients .” 2020. Doctoral Dissertation, University of Arizona. Accessed March 07, 2021. http://hdl.handle.net/10150/636692.

MLA Handbook (7^th Edition):

Mohan, Prashanthinie. “Geographic and Racial Disparities in Mortality of Dialysis Patients .” 2020. Web. 07 Mar 2021.

Vancouver:

Mohan P. Geographic and Racial Disparities in Mortality of Dialysis Patients . [Internet] [Doctoral dissertation]. University of Arizona; 2020. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10150/636692.

Council of Science Editors:

Mohan P. Geographic and Racial Disparities in Mortality of Dialysis Patients . [Doctoral Dissertation]. University of Arizona; 2020. Available from: http://hdl.handle.net/10150/636692

Queens University

18. Corrigan, Rebecca. The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis .

Degree: Nursing, 2011, Queens University

URL: http://hdl.handle.net/1974/6724

► Background: The growth in the number of individuals with end-stage renal disease has implications in terms of both the health of individuals, especially older adults… (more)

▼ Background: The growth in the number of individuals with end-stage renal disease has implications in terms of both the health of individuals, especially older adults (aged 65 years and older), and the capacity of the health care system to provide adequate treatment needed by these patients. Much has been written regarding the pathophysiology of end-stage renal disease as well as how modern advances in technology have contributed to the ‘dialysis world’. However, the literature is sparse in relation to how older adults experience end-stage renal disease and the technological complexity of dialysis in their daily lives. Objective: The purpose of this study was to explore the meaning of being hemodialysis-dependent for the older adult living with end-stage renal disease. Method: A descriptive method using a qualitative interviewing approach was used. Systematic focused thematic analysis guided by the Crisis of Physical Illness conceptual model allowed for the findings to surface. Data sources included individual interviews, direct observation of participants and the hemodialysis unit, along with field notes. A purposive sample of nine participants was obtained from two different hemodialysis units, both operated by Kingston General Hospital. Data were analyzed using the Colaizzi method. Findings: Five themes were identified by the participants: The Will to Live, Recognition of a Lifetime Commitment, Learning to Live with Technology, The Yin and Yang of Dialysis, and Transcending Dialysis. Conclusions: End-stage renal disease and thrice weekly hemodialysis treatment have an impact on the daily life of older adults and their ability to cope with the changes. This study revealed that despite the restrictions of being on hemodialysis, all of the participants had the will to live and some expressed the need for further education using a variety of strategies that would meet the specific needs of this population. A more in-depth understanding of how older adults experience hemodialysis is needed to provide adequate care/resources for this special population.

Subjects/Keywords: Hemodialysis ; Experience ; Older Adult ; End-Stage Renal Disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Corrigan, R. (2011). The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/6724

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Corrigan, Rebecca. “The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis .” 2011. Thesis, Queens University. Accessed March 07, 2021. http://hdl.handle.net/1974/6724.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Corrigan, Rebecca. “The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis .” 2011. Web. 07 Mar 2021.

Vancouver:

Corrigan R. The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis . [Internet] [Thesis]. Queens University; 2011. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1974/6724.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Corrigan R. The Experience of the Older Adult With End-Stage Renal Disease on Hemodialysis . [Thesis]. Queens University; 2011. Available from: http://hdl.handle.net/1974/6724

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Kwame Nkrumah University of Science and Technology

19. Asamoah-Boadi, Helen. Biochemical and Haematological Profile of Diabetic Nephropathy.

Degree: 2012, Kwame Nkrumah University of Science and Technology

URL: http://dspace.knust.edu.gh:8080/jspui/handle/123456789/5754

►

Background: Diabetic nephropathy, a microvascular complication of diabetes mellitus is now considered to be the leading known cause of end-stage renal disease (ESRD) in most… (more)

Subjects/Keywords: Microalbuminuria; Diabetic Nephropathy; Diabetes Mellitus; End Stage Renal Disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Asamoah-Boadi, H. (2012). Biochemical and Haematological Profile of Diabetic Nephropathy. (Thesis). Kwame Nkrumah University of Science and Technology. Retrieved from http://dspace.knust.edu.gh:8080/jspui/handle/123456789/5754

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Asamoah-Boadi, Helen. “Biochemical and Haematological Profile of Diabetic Nephropathy.” 2012. Thesis, Kwame Nkrumah University of Science and Technology. Accessed March 07, 2021. http://dspace.knust.edu.gh:8080/jspui/handle/123456789/5754.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Asamoah-Boadi, Helen. “Biochemical and Haematological Profile of Diabetic Nephropathy.” 2012. Web. 07 Mar 2021.

Vancouver:

Asamoah-Boadi H. Biochemical and Haematological Profile of Diabetic Nephropathy. [Internet] [Thesis]. Kwame Nkrumah University of Science and Technology; 2012. [cited 2021 Mar 07]. Available from: http://dspace.knust.edu.gh:8080/jspui/handle/123456789/5754.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Asamoah-Boadi H. Biochemical and Haematological Profile of Diabetic Nephropathy. [Thesis]. Kwame Nkrumah University of Science and Technology; 2012. Available from: http://dspace.knust.edu.gh:8080/jspui/handle/123456789/5754

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

20. Fisher, Amanda Kaye. Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis.

Degree: PhD, Genetics, Bioinformatics and Computational Biology, 2018, Virginia Tech

URL: http://hdl.handle.net/10919/92590

► Raman spectroscopy records the inelastic scattering of photons originating from striking a sample with monochromatic light. Inelastic, or Raman, scattered photons shift in wavelength due… (more)

▼ Raman spectroscopy records the inelastic scattering of photons originating from striking a sample with monochromatic light. Inelastic, or Raman, scattered photons shift in wavelength due to excitation of the vibrational modes of molecules struck by the incident light. The Raman scattered photons are representative of all of the covalent bonds contained within a sample. Raman spectra taken of biological systems such as proteins, bacterial colonies, and liquid waste, are difficult to interpret due to the complexity of their covalent bond landscape and mixtures of molecules in highly variable concentrations. Rather than deconstructing Raman spectra to attempt assignment of specific bonds and functional groups to wavenumber peaks, here we have developed a chemometric analysis pipeline for quantifying the similarities and differences among a set of Raman spectra. This quantification aids in both classification of samples, and in measuring how samples change over time. The chemometric approach for interpretation of Raman spectra was made freely available in a user-friendly format via a MATLAB add-on called the Raman Data Analysis (RDA) Toolbox. Demonstrations of the RDA Toolbox functionalities on Raman spectra taken of various common biological systems are included, such as determination of protein concentration and monitoring bacterial culture growth. The RDA Toolbox and Raman spectroscopy are also used to initiate research in novel areas. Fast and accurate evaluation of enzyme specific activity is required for engineering enzymes, and results of Raman assays, evaluated in the RDA Toolbox, are successfully correlated to absorbance activity assays of an enzyme WT and mutant library. Further development of this research could alleviate the bottleneck of screening mutant libraries in enzyme engineering projects. The Toolbox is then used in a distinctly different application for evaluating urine and spent dialysate samples from patients with end stage renal disease. Categorization between samples from healthy volunteers and patients is accomplished with close to 100% accuracy, and evidence indicating that Raman spectroscopy can serve as an early diagnostic tool for infections of the peritoneal membrane is presented. Advisors/Committee Members: Senger, Ryan S. (committeechair), Bevan, David R. (committeechair), Zhang, Chenming (committee member), Sobrado, Pablo (committee member), Robertson, John L. (committee member).

Subjects/Keywords: Enzyme Engineering; Raman Spectroscopy; Chemometrics; End Stage Renal Disease

10 more images…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Fisher, A. K. (2018). Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/92590

Chicago Manual of Style (16^th Edition):

Fisher, Amanda Kaye. “Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis.” 2018. Doctoral Dissertation, Virginia Tech. Accessed March 07, 2021. http://hdl.handle.net/10919/92590.

MLA Handbook (7^th Edition):

Fisher, Amanda Kaye. “Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis.” 2018. Web. 07 Mar 2021.

Vancouver:

Fisher AK. Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis. [Internet] [Doctoral dissertation]. Virginia Tech; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10919/92590.

Council of Science Editors:

Fisher AK. Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis. [Doctoral Dissertation]. Virginia Tech; 2018. Available from: http://hdl.handle.net/10919/92590

University of New South Wales

21. Chan, Ramony Chi Yung. Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation.

Degree: Psychiatry, 2011, University of New South Wales

URL: http://handle.unsw.edu.au/1959.4/51308 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9989/SOURCE02?view=true

► Studying psychosocial adaptation in end-stage renal disease (ESRD) is increasingly important in explaining the variability in health outcomes unaccounted for by clinical factors alone. An… (more)

▼ Studying psychosocial adaptation in end-stage renal disease (ESRD) is increasingly important in explaining the variability in health outcomes unaccounted for by clinical factors alone. An empirically validated model is needed for guiding this body of research. The broad objective of this thesis is to study psychosocial adaptation in ESRD by validating a biopsychosocial model and examining the impact of psychosocial factors in ESRD across the developmental stages, namely, predialysis, early and long-term dialysis. This thesis employed meta-regression analysis, factor analysis, and structural equation modelling (SEM); and examined twelve latent variables: quality of life (QoL), depression, positive affect, medical comorbidity, kidney disease symptom status, illness accommodation, physical functioning, kidney-disease-related loss (KDRL), self-efficacy, illness acceptance, social support, and haemoglobin.The systematic and meta-analytic reviews identified the strength of the overall associations of psychosocial factors to depression and QoL to be at a medium level, with cognitive appraisal and personality attributes having the largest associations with depression; and stress, affect and cognitive appraisal having the largest associations with QoL. The results supported the validity and reliability of Kidney Disease Loss Scale and that KDRL in ESRD is a distinct construct which may contribute to the level of depression. The results of the SEM analyses supported the validity and consistency of the proximal-distal model. It provided an empirical framework for integrating clinical, functional, psychosocial factors and health outcomes in ESRD. The findings demonstrated that a biopsychosocial model, formed by adding psychosocial factors onto the proximal-distal model, was valid for studying psychosocial adaptation and varied with the developmental stages. Among the psychosocial factors, illness acceptance had the least impact. Social support, KDRL, self-efficacy, and illness accommodation affected kidney disease symptom status, physical functioning, depression, positive affect, and QoL differently at each of the developmental stages. This thesis validated an empirical model for studying psychosocial adaptation to ESRD; supported the evolving and dynamic nature of psychosocial adaptation, and demonstrated the importance of psychosocial factors in determining health outcomes in patients with ESRD across the developmental stages. The results also supported the possible development of psychosocial support programs for patients with ESRD to improve their health outcomes. Advisors/Committee Members: Robert, Brooks, Psychiatry, Faculty of Medicine, UNSW, Jonathan , Erlich, Clinical School - Prince of Wales Hospital, Faculty of Medicine, UNSW, Michael, Suranyi, Clinical School - South Western Sydney, Faculty of Medicine, UNSW.

Subjects/Keywords: Model development; End Stage Renal Disease; Psychosocial adaptation; Dialysis

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Chan, R. C. Y. (2011). Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/51308 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9989/SOURCE02?view=true

Chicago Manual of Style (16^th Edition):

Chan, Ramony Chi Yung. “Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation.” 2011. Doctoral Dissertation, University of New South Wales. Accessed March 07, 2021. http://handle.unsw.edu.au/1959.4/51308 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9989/SOURCE02?view=true.

MLA Handbook (7^th Edition):

Chan, Ramony Chi Yung. “Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation.” 2011. Web. 07 Mar 2021.

Vancouver:

Chan RCY. Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation. [Internet] [Doctoral dissertation]. University of New South Wales; 2011. [cited 2021 Mar 07]. Available from: http://handle.unsw.edu.au/1959.4/51308 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9989/SOURCE02?view=true.

Council of Science Editors:

Chan RCY. Studying psychosocial adaptation to end-stage renal disease: empirical model development and evaluation. [Doctoral Dissertation]. University of New South Wales; 2011. Available from: http://handle.unsw.edu.au/1959.4/51308 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:9989/SOURCE02?view=true

22. Horvat Davey, Christine Marie. Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease.

Degree: PhD, Nursing, 2019, Case Western Reserve University School of Graduate Studies

URL: http://rave.ohiolink.edu/etdc/view?acc_num=case1564493520748895

► Fatigue is a prevalent and challenging symptom experienced by individuals with end stage renal disease (ESRD) on hemodialysis. Fatigue is associated with decreased quality of… (more)

Subjects/Keywords: Nursing; Genetics; end stage renal disease, fatigue, gene expression, depression

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Horvat Davey, C. M. (2019). Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease. (Doctoral Dissertation). Case Western Reserve University School of Graduate Studies. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=case1564493520748895

Chicago Manual of Style (16^th Edition):

Horvat Davey, Christine Marie. “Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease.” 2019. Doctoral Dissertation, Case Western Reserve University School of Graduate Studies. Accessed March 07, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1564493520748895.

MLA Handbook (7^th Edition):

Horvat Davey, Christine Marie. “Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease.” 2019. Web. 07 Mar 2021.

Vancouver:

Horvat Davey CM. Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease. [Internet] [Doctoral dissertation]. Case Western Reserve University School of Graduate Studies; 2019. [cited 2021 Mar 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1564493520748895.

Council of Science Editors:

Horvat Davey CM. Gene Expression Profiling of Fatigue in Individuals with End Stage Renal Disease. [Doctoral Dissertation]. Case Western Reserve University School of Graduate Studies; 2019. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1564493520748895

University of Toronto

23. Barbour, Sean. Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease.

Degree: 2012, University of Toronto

URL: http://hdl.handle.net/1807/67205

►

IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia; while this may be partly due to a higher prevalence of… (more)

Subjects/Keywords: IgA nephropathy; race; ethnicity; end-stage renal disease; renal progression; 0564; 0766

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Barbour, S. (2012). Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/67205

Chicago Manual of Style (16^th Edition):

Barbour, Sean. “Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease.” 2012. Masters Thesis, University of Toronto. Accessed March 07, 2021. http://hdl.handle.net/1807/67205.

MLA Handbook (7^th Edition):

Barbour, Sean. “Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease.” 2012. Web. 07 Mar 2021.

Vancouver:

Barbour S. Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease. [Internet] [Masters thesis]. University of Toronto; 2012. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1807/67205.

Council of Science Editors:

Barbour S. Asians With IgA Nephropathy Have An Increased Risk of Progression to End-stage Renal Disease. [Masters Thesis]. University of Toronto; 2012. Available from: http://hdl.handle.net/1807/67205

24. Sharma, Sumeet. Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy.

Degree: Thesis (M.D.), 2015, University of Hertfordshire

URL: http://hdl.handle.net/2299/17114

► End stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Despite the advances in both Cardiovascular… (more)

Subjects/Keywords: 616.6; thrombosis; Spontaneous thrombolysis; Platelet function testing; Renal replacement therapy (RRT); Haemodialysis; ESRD (end stage renal disease); Cardiac events

…Estimated Glomerular Filtration Rate ESRD End stage renal disease GP Glycoprotein GTT Global… …x28;CVD) in end stage renal disease (ESRD) patients and review the possible… …225-249 [Sumeet Sharma] Page 9 ABSTRACT Aims: End stage renal disease (… …end-stage renal disease. Sumeet Sharma, Ken Farrington, Robert Kozarski, Christos… …in end stage renal disease. Sumeet Sharma, Ken Farrington, Christos Christopoulos, Robert…

15 more images…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Sharma, S. (2015). Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy. (Doctoral Dissertation). University of Hertfordshire. Retrieved from http://hdl.handle.net/2299/17114

Chicago Manual of Style (16^th Edition):

Sharma, Sumeet. “Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy.” 2015. Doctoral Dissertation, University of Hertfordshire. Accessed March 07, 2021. http://hdl.handle.net/2299/17114.

MLA Handbook (7^th Edition):

Sharma, Sumeet. “Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy.” 2015. Web. 07 Mar 2021.

Vancouver:

Sharma S. Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy. [Internet] [Doctoral dissertation]. University of Hertfordshire; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2299/17114.

Council of Science Editors:

Sharma S. Thrombotic risk assessment in end stage renal disease patients on renal replacement therapy. [Doctoral Dissertation]. University of Hertfordshire; 2015. Available from: http://hdl.handle.net/2299/17114

Universidad del Rosario

25. Moreno Prieto, Diego Fernando. Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá.

Degree: 2017, Universidad del Rosario

URL: http://repository.urosario.edu.co/handle/10336/13832

► Introducción: las infecciosas son la segunda causa de hospitalización y mortalidad en los pacientes con enfermedad renal crónica en diálisis. Existen varios estudios que describen… (more)

▼ Introducción: las infecciosas son la segunda causa de hospitalización y mortalidad en los pacientes con enfermedad renal crónica en diálisis. Existen varios estudios que describen los días de estancia hospitalaria que se requieren para controlar las descompensaciones agudas de las enfermedades de base o las complicaciones derivadas de la terapia de reemplazo renal. Objetivo: determinar las diferencias en la hospitalización que se deriva del manejo de patologías infecciosas en pacientes con enfermedad renal crónica, comparando los pacientes que se encuentran en hemodiálisis, con los de diálisis peritoneal. Metodología: estudio de cohorte retrospectiva, dinámica, de pacientes en hemodiálisis y diálisis peritoneal que ingresan al servicio de urgencias del Hospital Universitario Mayor por patologías infecciosas. Los pacientes que ingresaron al estudio se incluyeron por métodos no probabilísticos. El cálculo de tamaño de muestra se realizó por comparación de medias, dado que se quiso encontrar diferencias entre el promedio de días de hospitalización en pacientes en hemodiálisis y diálisis peritoneal. Para el análisis estadístico se incluyeron 172 pacientes en hemodiálisis y 85 en diálisis peritoneal Resultados: en orden, las infecciones que generaron hospitalización en pacientes en diálisis fueron: osteomusculares y tejidos blandos (24,1%), Infección relacionada con la terapia de reemplazo renal (22,6%), infecciones respiratorias (22,2%), infecciones gastrointestinales (15,2%), infecciones en sistema nervioso central (1,9%). El promedio de hospitalización es mayor 2 días en pacientes con hemodiálisis en comparación con los pacientes en diálisis peritoneal, 12 vs 10 días respectivamente, p = 0,004. Se encontró relación entre hipoalbuminemia y mortalidad RR 1,25 (IC 95% 1,07 – 1,47). Por otro lado, las hospitalizaciones que duran 14 días o más, están relacionadas con hipoalbuminemia RR = 1,71 (IC 95% = 1,18 – 2.46), necesidad de transfusión de glóbulos rojos RR =2,53 (IC 95% = 1,90 – 3,37) y procedimientos quirúrgicos necesarios para el control de la infección, RR = 2,17 (IC 95% = 1,61 – 2,91). Conclusiones: este estudio evidencia que el tiempo de hospitalización por casusas infecciosas es mayor en pacientes en hemodiálisis que los de diálisis peritoneal, la razón de ello no es explicada por las variables estudiadas. Son diferentes las variables que explican el tiempo de hospitalización en pacientes en hemodiálisis y los de diálisis peritoneal. Advisors/Committee Members: Sanabria Arenas, Rafael Mauricio.

Subjects/Keywords: 616; End-Stage Kidney Disease; Chronic Kidney Failure; End-Stage Renal Disease; Hospitalization; Length of Stay; Inpatient; Infection; Dialyses; Peritoneal; Hemodialysis; Fallo Renal Crónico; Diálisis; Enfermedades Peritoneales; Diálisis Renal

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Moreno Prieto, D. F. (2017). Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá. (Thesis). Universidad del Rosario. Retrieved from http://repository.urosario.edu.co/handle/10336/13832

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Moreno Prieto, Diego Fernando. “Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá.” 2017. Thesis, Universidad del Rosario. Accessed March 07, 2021. http://repository.urosario.edu.co/handle/10336/13832.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Moreno Prieto, Diego Fernando. “Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá.” 2017. Web. 07 Mar 2021.

Vancouver:

Moreno Prieto DF. Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá. [Internet] [Thesis]. Universidad del Rosario; 2017. [cited 2021 Mar 07]. Available from: http://repository.urosario.edu.co/handle/10336/13832.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Moreno Prieto DF. Diferencias en la hospitalización por causas infecciosas entre pacientes con hemodiálisis y diálisis peritoneal en un hospital de Bogotá. [Thesis]. Universidad del Rosario; 2017. Available from: http://repository.urosario.edu.co/handle/10336/13832

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Ottawa

26. Atanya, Monica. The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy .

Degree: 2011, University of Ottawa

URL: http://hdl.handle.net/10393/19875

► Relative changes are detectable in the blood of end-stage renal disease (ESRD) patients during hemodialysis (HD) treatment using optical spectroscopy. However, the potential impacts of… (more)

Subjects/Keywords: Chronic kidney disease; End-stage renal disease; Hemodialysis; Acid-base; Oxygenation; Heparin; Optical spectroscopy

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Atanya, M. (2011). The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/19875

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Atanya, Monica. “The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy .” 2011. Thesis, University of Ottawa. Accessed March 07, 2021. http://hdl.handle.net/10393/19875.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Atanya, Monica. “The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy .” 2011. Web. 07 Mar 2021.

Vancouver:

Atanya M. The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy . [Internet] [Thesis]. University of Ottawa; 2011. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10393/19875.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Atanya M. The Effects of Acid-Base Parameters, Oxygen and Heparin on the Ability to Detect Changes in the Blood Status of End-Stage Renal Disease Patients Undergoing Hemodialysis Using Whole Blood-Based Optical Spectroscopy . [Thesis]. University of Ottawa; 2011. Available from: http://hdl.handle.net/10393/19875

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Université Catholique de Louvain

27. Morelle, Johann. Mechanisms and regulation of water transport across the peritoneal membrane.

Degree: 2016, Université Catholique de Louvain

URL: http://hdl.handle.net/2078.1/179475

►

Peritoneal dialysis represents the major home-based dialysis modality for patients with end-stage renal disease. The capacity of the peritoneal membrane to transport water in response… (more)

Subjects/Keywords: Aquaporins; End-stage renal disease; Water transport; Peritoneal dialysis; Fibrosis; Chronic kidney disease

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Morelle, J. (2016). Mechanisms and regulation of water transport across the peritoneal membrane. (Thesis). Université Catholique de Louvain. Retrieved from http://hdl.handle.net/2078.1/179475

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Morelle, Johann. “Mechanisms and regulation of water transport across the peritoneal membrane.” 2016. Thesis, Université Catholique de Louvain. Accessed March 07, 2021. http://hdl.handle.net/2078.1/179475.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Morelle, Johann. “Mechanisms and regulation of water transport across the peritoneal membrane.” 2016. Web. 07 Mar 2021.

Vancouver:

Morelle J. Mechanisms and regulation of water transport across the peritoneal membrane. [Internet] [Thesis]. Université Catholique de Louvain; 2016. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2078.1/179475.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Morelle J. Mechanisms and regulation of water transport across the peritoneal membrane. [Thesis]. Université Catholique de Louvain; 2016. Available from: http://hdl.handle.net/2078.1/179475

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Illinois – Urbana-Champaign

28. Fitschen, Peter J. Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients.

Degree: PhD, Nutritional Sciences, 2015, University of Illinois – Urbana-Champaign

URL: http://hdl.handle.net/2142/89177

► Patients with renal failure undergoing maintenance hemodialysis (MHD) therapy suffer from a number of co-morbidities including skeletal muscle loss, reduced physical function, a significantly increased… (more)

▼ Patients with renal failure undergoing maintenance hemodialysis (MHD) therapy suffer from a number of co-morbidities including skeletal muscle loss, reduced physical function, a significantly increased fall risk, and reduced quality of life (QOL). Therefore, interventions to combat these co-morbidities are needed. Beta-hydroxy-beta-methylbutyrate (HMB) is a metabolite of the amino acid leucine that has been shown to improve lean mass and physical function in the elderly and clinical populations, but had not previously been studied in MHD patients. Approximately 25 percent of supplemental HMB is cleared by the kidney; therefore, we first performed an acute study to determine the clearance of supplemental HMB in hemodialysis patients. MHD patients (n=8) consumed 3g HMB prior to a standard hemodialysis session. Following supplementation with HMB, a majority of supplemental HMB was cleared within 48hrs and plasma HMB levels returned to baseline within 7 days in all participants. These results suggest that supplemental HMB is cleared in patients with impaired renal function. Based upon these results, we performed a double blind, placebo controlled, randomized trial to assess the effects of daily HMB supplementation on co-morbidities in MHD patients. MHD patients were recruited and assigned to either daily supplementation with HMB (n=16) or placebo (n=17) for 6 months. No significant effects of HMB on lean mass, strength, physical function, fall risk, or quality of life were found using an intent-to-treat analysis. However, upon analysis of plasma HMB concentrations, 5 of 16 patients (31%) who completed the study in the HMB group were found to be non-compliant at 3 or 6 months. Therefore, we performed a per-protocol analysis with compliant participants only. Although this analysis was underpowered, we observed a trend for improvements in chair stand and timed up-and-go tests with HMB supplementation. However, no effects of HMB were observed for lean mass, strength, fall risk, or quality of life. As a whole, these results do not support the efficacy of HMB to attenuate muscle loss and declines in physical function in MHD patients. However, the observed low-compliance with study pills may have affected results. Moreover, it highlights the need for future interventions targeted at reducing pill burden and improving pill compliance in this population. Advisors/Committee Members: Wilund, Kenneth R (advisor), Pan, Yuan-Xiang (Committee Chair), Woods, Jeffrey A (committee member), Wilson, Jacob M (committee member).

Subjects/Keywords: hemodialysis; muscle; kidney disease; end stage renal disease; Beta-hydroxy-beta-methylbutyrate (HMB)

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Fitschen, P. J. (2015). Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/89177

Chicago Manual of Style (16^th Edition):

Fitschen, Peter J. “Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients.” 2015. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed March 07, 2021. http://hdl.handle.net/2142/89177.

MLA Handbook (7^th Edition):

Fitschen, Peter J. “Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients.” 2015. Web. 07 Mar 2021.

Vancouver:

Fitschen PJ. Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2142/89177.

Council of Science Editors:

Fitschen PJ. Efficacy of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in hemodialysis patients. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2015. Available from: http://hdl.handle.net/2142/89177

29. Wang, Ruibin. The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America.

Degree: 2015, Johns Hopkins University

URL: http://jhir.library.jhu.edu/handle/1774.2/38064

► Background: Tenofovir disoproxil fumarate (TDF) was associated with an increased risk of renal toxicity, resulting in proximal tubular dysfunction, proteinuria, and chronic kidney disease (CKD).… (more)

▼ Background: Tenofovir disoproxil fumarate (TDF) was associated with an increased risk of renal toxicity, resulting in proximal tubular dysfunction, proteinuria, and chronic kidney disease (CKD). However, TDF-related nephrotoxicity has not been studied in the context of end-state renal disease (ESRD). We hypothesized that TDF-induced toxicity mainly affected a subset of susceptible HIV-infected patients that led to faster progression to ESRD. Methods: Data was extracted from 12 clinical cohorts under the North American AIDS Cohort Collaboration for Research and Design study that carried out systematic ESRD validation from January 2000 to December 2009. Piece-wise log-linear mixed effects models were used to compare and contrast estimated glomerular filtration rate (eGFR) trajectories in TDF and other nucleoside reverse transcriptase inhibitor (NRTI) therapy groups. A nested design was employed to identify risk factors associated with increased ESRD risk after TDF exposure. Results: Among the 19,653 patients, over 20% of high-risk individuals received less than two serum creatinine-based assessments of kidney function per year. For TDF users with baseline eGFR≥90, 60-89.9 and 45-59.9 mL/min/1.73m2, the annualized eGFR change decreased at -10.1% (p<-0.001), -9.9% (p<-0.001) and -27.2% (p<-0.001), respectively during the first 6 months after therapy initiation. In contrast, eGFR decreased at a slower rate or stabilized among alternative NRTI initiators during this period at rates of -5.9% (p<0.001), 0.7% (p=0.596) and 9.8% (p=0.027) for the same eGFR categories. For patients with baseline eGFR in ranges of 30-44.9 and <30 mL/min/1.73m2, eGFR change was non-significant at -14.0% (p=0.068) and -9.3% (p=0.617) per year, respectively among TDF initiators, whereas among alternative NRTI users, eGFR declined at -27.7% (p<0.001) and -31.2% (p<0.001) per year. Among TDF-exposed patients, black race was independently associated with 3.4 [95% CI: 1.2-9.6] times higher ESRD risk. Conclusion: Insufficient screening and monitoring of kidney function remains as an issue for clinical care of kidney diseases among HIV-infected patients. TDF-based therapies are associated with higher ESRD risks. TDF-induced toxicity mainly affects a small subset of susceptible individuals. Advisors/Committee Members: Abraham, Alison G (advisor).

Subjects/Keywords: HIV-infection; Tenofovir disoproxil fumarate (TDF); Nucleoside reverse transcriptase inhibitor (NRTI); End-stage renal Disease (ESRD); Glomerular filtration rate (GFR)

…developed incident end-stage renal disease (ESRD). Finally, we used a nested case… …eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; TDF, tenofovir… …estimated glomerular filtration rate; ESRD, end-stage renal disease; TDF, tenofovir disoproxil… …effects models. Abbreviations: eGFR, estimated glomerular filtration rate; ESRD, end-stage renal… …cohort-specific end date for ESRD verification, or administrative censoring (December 31…

2 more images…

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Wang, R. (2015). The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/38064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Wang, Ruibin. “The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America.” 2015. Thesis, Johns Hopkins University. Accessed March 07, 2021. http://jhir.library.jhu.edu/handle/1774.2/38064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Wang, Ruibin. “The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America.” 2015. Web. 07 Mar 2021.

Vancouver:

Wang R. The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America. [Internet] [Thesis]. Johns Hopkins University; 2015. [cited 2021 Mar 07]. Available from: http://jhir.library.jhu.edu/handle/1774.2/38064.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wang R. The impact of tenofovir disoproxil fumarate on estimated glomerular filtration rate change and progression to end-stage renal disease among HIV-infected adults in North America. [Thesis]. Johns Hopkins University; 2015. Available from: http://jhir.library.jhu.edu/handle/1774.2/38064

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Καϊτελίδου, Δάφνη. Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης.

Degree: 2002, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

URL: http://hdl.handle.net/10442/hedi/16108

► One of the most critical policy issues in the last years has been the rising cost of health care and the efficiency and effectiveness of… (more)

▼ One of the most critical policy issues in the last years has been the rising cost of health care and the efficiency and effectiveness of resource use. At the same time, it has been established that, while health technology is a major cost driving factor, its appropriate utilization also improves the quality and effectiveness of care. As far as End Stage Renal Disease is concerned, the technology of hemodialysis seems to be a well established form of treatment. Yet, major problems arise due to the high cost (direct and indirect) of this method and the frequency of the treatments needed (normally four hours three times per week). Existing evidence from the international literature along with the absence of estimates of the actual cost of inpatient dialysis, points to the need for an economic evaluation study of the cost of the dialysis in a national setting. In this study, we estimated the cost of hemodialysis treatment in a public hospital setting, along with the lost productivity cost of these patients (loss of income) which was particularly difficult exercise, but in the case of end-stage renal disease this item enters the cost structure in a rather decisive way, since absence from or even loss of work are fairly common outcomes of the disease. Material and methods: A socioeconomic analysis was performed attempting the economic evaluation of: a) the health care resources consumed in order to provide hemodialysis therapy for ESRD patients and b) the lost productivity cost of the patient and their family due to illness. The direct cost of illness was estimated in “G. Gennimatas” Hospital of Athens, which includes a dialysis unit currently providing ESRD care for 26 permanent patients utilizing 9 hemodialysis stations. The unit operates six days a week for ten hours/day performing approximately 7,000 hemodialysis treatments per year (for the permanent and the non-permanent patients. The study was carried out from a societal perspective. In addition to direct medical and non-medical costs, lost productivity costs often have a substantial impact on the total cost-of-illness. According to the recent Canadian Guidelines, indirect costs are the value of production lost as a result of the illness or the treatment process. In this study we estimated the lost productivity costs for the patient with both the human capital approach and the friction method. Indirect morbidity costs due to absence from work, long-term disability necessitating a change in type of work, or early retirement were estimated as well as mortality costs. Cost data expressed in 1999 Greek drachmas and euro, were collected from a sample of 128 patients. Mean gross income was used for both patient and family. Results: It was estimated that hemodialysis costs more than 62,000dr. (182 Euro) per treatment and the hospitalization more than 78.000dr/inpatient day (229 Euro). 46,1% of the patients were hospitalized for 8,5 days in the Nephrological Unit of the hospital (95%confidence interval:3,2-13,7, standard deviation: 8,3). The total direct cost of…

Subjects/Keywords: Οικονομική αποτίμηση; Αιμοκάθαρση, Κόστος; Χρόνια νεφρική ανεπάρκεια (ΧΝΑ), Κόστος; Παραγωγικότητα, Απώλεια; Economic evaluation; Hemodialysis cost; End stage renal disease (ESRD), Cost; Productivity, Lost cost

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Καϊτελίδου, . �. (2002). Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/16108

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Καϊτελίδου, Δάφνη. “Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης.” 2002. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed March 07, 2021. http://hdl.handle.net/10442/hedi/16108.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Καϊτελίδου, Δάφνη. “Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης.” 2002. Web. 07 Mar 2021.

Vancouver:

Καϊτελίδου �. Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2002. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10442/hedi/16108.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Καϊτελίδου �. Οικονομική αποτίμηση του κόστους της ενδονοσοκομειακής αιμοκάθαρσης. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2002. Available from: http://hdl.handle.net/10442/hedi/16108

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

		in
And / Or
		in
And / Or
		in
And / Or
		in

Open Access Theses and Dissertations